NanoGroup SA engages in the medical research and development. It develops diagnostic, therapeutic and rehabilitation tools for oncology patients. The company's projects include Nanovelos, NanoSanguis and NanoTHEA. NanoGroup was founded by Tomasz Adam Ciach on December 2, 2016 and is headquartered Warsaw, Poland.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company